Search Within

John Crown

Formats
  1. Journal Article (29)
  2. Meeting Abstract (12)
  3. Conference Paper (5)
  4. Book Section (1)
Groups
  1. Department of Medicine (46)
  2. Solid Tumor Oncology Division (41)
  3. Breast Medicine Service (35)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (34)
  5. Survivorship Research (27)
  6. Hematologic Malignancies, Division of (25)

More Groups

People
  1. Larry Norton (34)
  2. Teresa Gilewski (20)
  3. Clifford Hudis (19)
  4. David Fennelly (19)
  5. Lilian Reich (19)
  6. Tzy-Jyun Yao (18)

More People

Years
  1. 1999 (2)
  2. 1998 (1)
  3. 1997 (1)
  4. 1996 (2)
  5. 1995 (6)
  6. 1994 (11)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Blood (8)
  3. Seminars in Oncology (4)
  4. Cancer (3)
  5. Annals of the New York Academy of Sciences (2)
  6. Breast Cancer Research and Treatment (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Society of Hematology (8)
  3. American Association for Cancer Research (4)
  4. Elsevier Inc. (4)
  5. John Wiley & Sons (3)
  6. Springer (3)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paclitaxel as second and subsequent therapy for metastatic breast cancer: Activity independent of prior anthracycline response
    Journal Article

    Seidman, A. D.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Currie, V.; Hakes, T. B.; Hudis, C. A.; Gilewski, T. A.; Baselga, J.; Forsythe, P.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save
  • Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer
    Journal Article

    Vahdat, L.; Raptis, G.; Fennelly, D.; Hamilton, N.; Reich, L.; Tiersten, A.; Harrison, M.; Hudis, C.; Moore, M.; Yao, T. J.; more...
    Clinical Cancer Research (1995)

    Fulltext@MSK | Save
  • Taxol in combination with cyclophosphamide and GCSF, a novel peripheral blood progenitor cell mobilizing regimen
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Hakes, T.; Spriggs, D.; Reich, L.; Yao, T. J.; Shapiro, F.; Norton, L.; Moore, M. A. S.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Treatment of advanced ovarian cancer (AOC) with high-dose (HD) carboplatin (C) and escalating-dose taxol (TXL) with cyclophosphamide (CTX)/TXL-primed peripheral blood progenitor cells (PBP) as hematological support (HS): A phase I study
    Meeting Abstract

    Fennelly, D.; Schneider, J.; Hakes, T.; Crown, J.; Bengala, C.; Reich, L.; Moore, M.; Gulati, S.; Shapiro, F.; Barakat, R.; more...
    Gynecologic Oncology (1994)

    Fulltext@MSK | Save
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Rapidly administered sequential high dose(HD) cyclophosphamide(CPA), melphalan(M), thiotepa(TT) supported by filgrastim(G) + peripheral blood progenitors(PBP) in metastatic breast cancer(MBC) patients(PTS)
    Meeting Abstract

    Raptis, G.; Crown, J.; Vahdat, L.; Fennelly, D.; Hamilton, N.; Hudis, C.; Gilewski, T.; Seidman, A.; Currie, V.; Reich, L.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Peripheral blood progenitor cell (PBP) mobilization using Taxol (T) in combination with cyclophosphamide (C) and GCSF; Quantitation and correlation of CD34+ cell count, colony-forming-unit granulocyte-macrophage (CFU-GM), and mononuclear cell (MNC) count
    Meeting Abstract

    Fennelly, D.; Bengala, C.; Schneider, J.; Reich, L.; Norton, L.; Spriggs, D.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • Long-term hematopoiesis is not affected by rapid cycling of sequential high dose chemotherapy (HDC) prior to full hematologic recovery
    Meeting Abstract

    Tiersten, A.; Raptis, G.; Crown, J.; Vahdat, L.; Hamilton, N.; Reich, L.; Damaskos, P.; Norton, L.
    Blood (1994)

    Fulltext@MSK | Save
  • Comparative efficacy of bone marrow engraftment following high-dose (HD) carboplatin (CBDCA) plus cyclophosphamide versus high-dose CBDCA/Taxol (TXL), when rescued with TXL cyclophosphamide (CPA) and GCSF mobilized peripheral blood progenitor cells (PBP)
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Schneider, J.; Spriggs, D.; Bengala, C.; McKenzie, M.; Reich, L.; Norton, L.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • High-intensity chemotherapy with peripheral blood progenitor cell support
    Conference Paper

    Fennelly, D.; Vahdat, L.; Schneider, J.; Reich, L.; Hamilton, N.; Hakes, T.; Raptis, G.; Wasserheit, C.; Kritz, A.; Gulati, S.; more...
    Elsevier Inc. (1994)

    Fulltext@MSK | Save